I TOLD MY DOCTOR I WANTED TO STOP TAKING MY OPIOID PAIN MEDICINE.

WE CAME UP WITH A PLAN.

Regardless of when you started taking opioids, stopping use suddenly can result in severe, sometimes flu-like, withdrawal symptoms.1

LUCEMYRA® is the only FDA-approved, non-opioid, non-addictive treatment for relief of multiple symptoms of opioid withdrawal that may happen when you stop taking an opioid suddenly.1

I TOLD MY DOCTOR I WANTED TO STOP TAKING MY OPIOID PAIN MEDICINE.

WE CAME UP WITH A PLAN.

Regardless of when you started taking opioids, stopping use suddenly can result in severe, sometimes flu-like, withdrawal symptoms.1

LUCEMYRA® is the only FDA-approved, non-opioid, non-addictive treatment for relief of multiple symptoms of opioid withdrawal that may happen when you stop taking an opioid suddenly.1

WHAT IS OPIOID WITHDRAWAL SYNDROME?

Stopping opioid use can result in severe, sometimes flu-like, symptoms that are known as Opioid Withdrawal Syndrome (OWS).2

LUCEMYRA PRESCRIPTION SAVINGS PROGRAM

Eligible patients will pay $0* for LUCEMYRA.
*See Terms and Conditions for details.

LUCEMYRA PRESCRIPTION SAVINGS PROGRAM

Eligible patients will pay $0* for LUCEMYRA.
*See Terms and Conditions for details.

DOCTOR DISCUSSION GUIDE

Use our interactive discussion guide to start a conversation about opioid withdrawal with your healthcare provider.

RELIEF WITH LUCEMYRA

LUCEMYRA helped patients when their withdrawal symptoms were most severe.1,3

RELIEF WITH LUCEMYRA

LUCEMYRA helped patients when their withdrawal symptoms were most severe.1,3

GET THE LUminate™ SUPPORT APP

The LUminate Support App is designed to assist patients taking LUCEMYRA as they go through opioid withdrawal. Use the app to set medication reminders, get helpful advice, receive encouragement, and more!

AVAILABLE AT:

References

  1. LUCEMYRA® (lofexidine) [Prescribing Information]. Louisville, KY: US WorldMeds, LLC; 2018.
  2. Shigakova F. Clinical manifestations of the opiate withdrawal syndrome. Int J Biomed. 2015;5(3):151-154.
  3. Data on file. Louisville, KY: US WorldMeds; 2017.